JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB187481

Recombinant Human GBA3 protein (His tag)

Be the first to review this product! Submit a review

|

(0 Publication)

Recombinant Human GBA3 protein (His tag) is a Human Full Length protein, in the 1 to 469 aa range, expressed in Escherichia coli, with >85%, suitable for SDS-PAGE.

View Alternative Names

CBG, CBGL1, GBA3, Cytosolic beta-glucosidase, Cytosolic beta-glucosidase-like protein 1, Cytosolic galactosylceramidase, Cytosolic glucosylceramidase, Cytosolic glycosylceramidase, Glucosidase beta acid 3, Glucosylceramidase beta 3, Klotho-related protein, Cytosolic GCase, KLrP

1 Images
SDS-PAGE - Recombinant Human GBA3 protein (His tag) (AB187481)
  • SDS-PAGE

Supplier Data

SDS-PAGE - Recombinant Human GBA3 protein (His tag) (AB187481)

15% SDS-PAGE analysis of 3μg ab187481.

Key facts

Purity

>85% SDS-PAGE

Expression system

Escherichia coli

Tags

His tag N-Terminus

Applications

SDS-PAGE

applications

Biologically active

No

Accession

Q9H227

Animal free

No

Carrier free

No

Species

Human

Storage buffer

pH: 7.4 Constituents: PBS, 20% Glycerol (glycerin, glycerine), 0.02% (R*,R*)-1,4-Dimercaptobutan-2,3-diol

storage-buffer

style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }
style
left-column
style
left-column

Sequence info

[{"sequence":"MGSSHHHHHHSSGLVPRGSHMGSMAFPAGFGWAAATAAYQVEGGWDADGKGPCVWDTFTHQGGERVFKNQTGDVACGSYTLWEEDLKCIKQLGLTHYRFSLSWSRLLPDGTTGFINQKGIDYYNKIIDDLLKNGVTPIVTLYHFDLPQTLEDQGGWLSEAIIESFDKYAQFCFSTFGDRVKQWITINEANVLSVMSYDLGMFPPGIPHFGTGGYQAAHNLIKAHARSWHSYDSLFRKKQKGMVSLSLFAVWLEPADPNSVSDQEAAKRAITFHLDLFAKPIFIDGDYPEVVKSQIASMSQKQGYPSSRLPEFTEEEKKMIKGTADFFAVQYYTTRLIKYQENKKGELGILQDAEIEFFPDPSWKNVDWIYVVPWGVCKLLKYIKDTYNNPVIYITENGFPQSDPAPLDDTQRWEYFRQTFQELFKAIQLDKVNLQVYCAWSLLDNFEWNQGYSSRFGLFHVDFEDPARPRVPYTSAKEYAKIIRNNGLEAHL","proteinLength":"Full Length","predictedMolecularWeight":"56.1 kDa","actualMolecularWeight":null,"aminoAcidEnd":469,"aminoAcidStart":1,"nature":"Recombinant","expressionSystem":"Escherichia coli","accessionNumber":"Q9H227","tags":[{"tag":"His","terminus":"N-Terminus"}]}]
style
left-column

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle
False
style
left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

GBA3 also known as cytosolic beta-glucosidase is an enzyme with a molecular mass of approximately 60 kDa. This protein functions to hydrolyze glycosides specifically beta-D-glucosides and other saccharide derivatives facilitating the breakdown of these molecules into useful substrates for the cell. GBA3 is expressed in various tissues such as liver kidney and small intestine indicating its widespread role in metabolism.
Biological function summary

Enzymes like cytosolic beta-glucosidase contribute to essential digestive and metabolic processes by breaking down glycosidic bonds found in complex carbohydrates. They are not part of a larger protein complex but they cooperate with other enzymes to maintain energy production from dietary sources. This activity helps the organism to manage carbohydrate metabolism effectively releasing simple sugars that cells use for energy.

Pathways

GBA3 interacts closely with glycolysis and gluconeogenesis important pathways for energy homeostasis. In these pathways GBA3's role in carbohydrate breakdown supplies simple sugars that enter further stages of energy production. It acts alongside proteins like glucokinase and phosphoglucomutase which also contribute to these metabolic pathways aiding in the management of energy resources in the body.

Abnormal activity or expression of GBA3 can link to metabolic conditions like Gaucher's disease and Niemann-Pick disease. These are lysosomal storage disorders where disruptions in glycoside processing can lead to harmful accumulation of glucosylceramides. Proteins such as glucocerebrosidase (GBA1) are also affected in these disorders highlighting a network where GBA3 activity is vital for preventing substrate buildup and maintaining cellular health.
style
left-column

Specifications

Form

Liquid

Additional notes

ab187481 was purified using conventional chromatography techniques.

style
left-column

General info

Function

Neutral cytosolic beta-glycosidase with a broad substrate specificity that could play a role in the catabolism of glycosylceramides (PubMed : 11389701, PubMed : 11784319, PubMed : 17595169, PubMed : 20728381, PubMed : 26724485, PubMed : 33361282). Has a significant glucosylceramidase activity in vitro (PubMed : 17595169, PubMed : 26724485). However, that activity is relatively low and its significance in vivo is not clear (PubMed : 17595169, PubMed : 20728381, PubMed : 26724485). Hydrolyzes galactosylceramides/GalCers, glucosylsphingosines/GlcSphs and galactosylsphingosines/GalSphs (PubMed : 17595169). However, the in vivo relevance of these activities is unclear (PubMed : 17595169). It can also hydrolyze a broad variety of dietary glycosides including phytoestrogens, flavonols, flavones, flavanones and cyanogens in vitro and could therefore play a role in the metabolism of xenobiotics (PubMed : 11784319). Possesses transxylosylase activity in vitro using xylosylated ceramides/XylCers (such as beta-D-xylosyl-(1<->1')-N-acylsphing-4-enine) as xylosyl donors and cholesterol as acceptor (PubMed : 33361282). Could also play a role in the catabolism of cytosolic sialyl free N-glycans (PubMed : 26193330).

Sequence similarities

Belongs to the glycosyl hydrolase 1 family. Klotho subfamily.

Post-translational modifications

The N-terminus is blocked.

style
left-column

Product protocols

style
left-column

Target data

Neutral cytosolic beta-glycosidase with a broad substrate specificity that could play a role in the catabolism of glycosylceramides (PubMed : 11389701, PubMed : 11784319, PubMed : 17595169, PubMed : 20728381, PubMed : 26724485, PubMed : 33361282). Has a significant glucosylceramidase activity in vitro (PubMed : 17595169, PubMed : 26724485). However, that activity is relatively low and its significance in vivo is not clear (PubMed : 17595169, PubMed : 20728381, PubMed : 26724485). Hydrolyzes galactosylceramides/GalCers, glucosylsphingosines/GlcSphs and galactosylsphingosines/GalSphs (PubMed : 17595169). However, the in vivo relevance of these activities is unclear (PubMed : 17595169). It can also hydrolyze a broad variety of dietary glycosides including phytoestrogens, flavonols, flavones, flavanones and cyanogens in vitro and could therefore play a role in the metabolism of xenobiotics (PubMed : 11784319). Possesses transxylosylase activity in vitro using xylosylated ceramides/XylCers (such as beta-D-xylosyl-(1<->1')-N-acylsphing-4-enine) as xylosyl donors and cholesterol as acceptor (PubMed : 33361282). Could also play a role in the catabolism of cytosolic sialyl free N-glycans (PubMed : 26193330).
See full target information GBA3
style
left-column
style
left-column
style
right-column

Complementary Products

Primary Antibodies

AB154897

Anti-GBA3 antibody

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GBA3 antibody (AB154897)

  • 0
  • 0

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com